Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chaitra S Ujjani

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|March 12, 2025
Immune Dysfunction and Consequences in Chronic Lymphocytic LeukemiaMayur Narkhede, Chaitra S Ujjani
British Journal of Haematology|July 9, 2016
Overestimated value of FDG-PET based bone marrow evaluation in lymphoma: Response to Adams and KweeChaitra S Ujjani, Bruce D Cheson
Cancer Cell|July 9, 2021
Immunogenicity of a heterologous COVID-19 vaccine after failed vaccination in a lymphoma patientJoshua A Hill, Chaitra S Ujjani, Alexander L Greninger, et al.
Case Reports in Hematology|October 2, 2018
Concurrent Diagnosis of Chronic Myeloid Leukemia and Follicular Lymphoma: An Unreported PresentationAmy G Starr, Sushma R Jonna, Joeffrey J Chahine, et al.
British Journal of Haematology|April 22, 2016
(18) F-FDG PET-CT and trephine biopsy assessment of bone marrow involvement in lymphomaChaitra S Ujjani, Elizabeth M Hill, Hongkun Wang, et al.
British Journal of Haematology|October 10, 2025
Long-term follow-up of dose-dense brentuximab vedotin, ifosfamide, carboplatin and etoposide in second-line treatment of relapsed/refractory classical Hodgkin lymphomaRyan C Lynch, Ryan D Cassaday, Stephen D Smith, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 24, 2025
Barriers to Investigator-Initiated Clinical Trial Enrollment in Frontline Large B-Cell LymphomaCarrie Ho, Neena Kennedy, Mengyang Di, et al.
JCO Oncology Practice|November 18, 2024
Clinical Relevance of Intensive Laboratory Monitoring With Standard Venetoclax Ramp-Up for Chronic Lymphocytic Leukemia: A Real-World ExperienceIvan J Huang, Grace T Baek, Jonathan Cohen, et al.
American Journal of Hematology|January 22, 2019
Eligibility for CAR T-cell therapy: An analysis of selection criteria and survival outcomes in chemorefractory DLBCLStephen D Smith, Prathima Reddy, Alexandra Sokolova, et al.
Blood Advances|June 17, 2025
Pralatrexate is effective in cytotoxic cutaneous T-cell lymphomasChristina Poh, Jenna M Voutsinas, Mazyar Shadman, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Journal of the National Comprehensive Cancer Network : JNCCN|March 12, 2025
Immune Dysfunction and Consequences in Chronic Lymphocytic LeukemiaMayur Narkhede, Chaitra S Ujjani
British Journal of Haematology|July 9, 2016
Overestimated value of FDG-PET based bone marrow evaluation in lymphoma: Response to Adams and KweeChaitra S Ujjani, Bruce D Cheson
Cancer Cell|July 9, 2021
Immunogenicity of a heterologous COVID-19 vaccine after failed vaccination in a lymphoma patientJoshua A Hill, Chaitra S Ujjani, Alexander L Greninger, et al.
Case Reports in Hematology|October 2, 2018
Concurrent Diagnosis of Chronic Myeloid Leukemia and Follicular Lymphoma: An Unreported PresentationAmy G Starr, Sushma R Jonna, Joeffrey J Chahine, et al.
British Journal of Haematology|April 22, 2016
(18) F-FDG PET-CT and trephine biopsy assessment of bone marrow involvement in lymphomaChaitra S Ujjani, Elizabeth M Hill, Hongkun Wang, et al.
British Journal of Haematology|October 10, 2025
Long-term follow-up of dose-dense brentuximab vedotin, ifosfamide, carboplatin and etoposide in second-line treatment of relapsed/refractory classical Hodgkin lymphomaRyan C Lynch, Ryan D Cassaday, Stephen D Smith, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 24, 2025
Barriers to Investigator-Initiated Clinical Trial Enrollment in Frontline Large B-Cell LymphomaCarrie Ho, Neena Kennedy, Mengyang Di, et al.
JCO Oncology Practice|November 18, 2024
Clinical Relevance of Intensive Laboratory Monitoring With Standard Venetoclax Ramp-Up for Chronic Lymphocytic Leukemia: A Real-World ExperienceIvan J Huang, Grace T Baek, Jonathan Cohen, et al.
American Journal of Hematology|January 22, 2019
Eligibility for CAR T-cell therapy: An analysis of selection criteria and survival outcomes in chemorefractory DLBCLStephen D Smith, Prathima Reddy, Alexandra Sokolova, et al.
Blood Advances|June 17, 2025
Pralatrexate is effective in cytotoxic cutaneous T-cell lymphomasChristina Poh, Jenna M Voutsinas, Mazyar Shadman, et al.
Pageof 4